Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncology Report

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR.18.2.497PMID 17611676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.

  2006cited by this paper
• Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.

  2006cited by this paper
• Crosstalk of oncogenic and prostanoid signaling pathways

  2004influential reference
• Colon Carcinoma Cell Growth Is Associated with Prostaglandin E2/EP4 Receptor-evoked ERK Activation*

  2004cited by this paper
• Cyclooxygenase 2 is a key enzyme for inflammatory cytokine‐induced angiogenesis

  2004cited by this paper
• Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.

  2003cited by this paper
• Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice

  2003cited by this paper
• Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth

  2003cited by this paper
• Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.

  2003cited by this paper
• Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.

  2003cited by this paper
• Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.

  2003cited by this paper
• Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps

  2002cited by this paper
• Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression.

  2002cited by this paper
• Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.

  2002cited by this paper
• Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.

  2002cited by this paper
• Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

  2002cited by this paper
• Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer.

  2002cited by this paper
• Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.

  2002cited by this paper
• Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer.

  2001cited by this paper
• Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo.

  2001cited by this paper
• Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2

  2001cited by this paper
• Indomethacin reduces lung adenoma number in A/J mice.

  2001cited by this paper
• Prostacyclin-dependent Apoptosis Mediated by PPARδ*

  2001cited by this paper
• Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice

  2001cited by this paper
• Distribution and Cellular Localization of Prostacyclin Synthase in Human Brain

  2000cited by this paper
• Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Cyclooxygenase‐dependent signalling: molecular events and consequences

  1999cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.

  1998cited by this paper
• Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice.

  1997cited by this paper
• Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry.

  1994cited by this paper
• Lecithin biosynthesis in a clonal line of lung adenoma cells with type II alveolar cell properties.

  1978cited by this paper

• New perspectives on the potential mechanisms, prevention and treatment of deep vein thrombosis complicated by lung cancer.

  2025cites this paper
• [Role of Prostaglandin Synthases in Carcinogenesis].

  2025cites this paper
• Fatty acids in cancer: Metabolic functions and potential treatment

  2023cites this paper
• miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention

  2022cites this paper
• New insights on unique therapeutic potentialities of prostacyclin and prostacyclin synthase

  2020cites this paper
• Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression

  2019cites this paper
• Eicosanoids and cancer

  2018cites this paper
• Prostaglandin terminal synthases as novel therapeutic targets

  2017cites this paper
• Role of prostacyclin synthase in carcinogenesis.

  2017cites this paper
• Expresión de prostaciclina sintetasa en los carcinomas de cabeza y cuello y valor pronóstico en la respuesta a radioterapia

  2015cites this paper
• Prostacyclin‐synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy

  2015cites this paper
• Clinical models and biochemical predictors of VTE in lung cancer

  2014cites this paper
• The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.

  2013cites this paper
• The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis

  2011cites this paper
• Prostacyclin administration as a beneficial supplement to the conventional cancer chemotherapy.

  2011cites this paper
• Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.

  2010cites this paper
• The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer.

  2010cites this paper
• The role of prostacyclin in lung cancer.

  2010cites this paper
• Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: Differential expression in non-small cell lung cancers.

  2010cites this paper
• Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications.

  2009cites this paper
• PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.

  2009cites this paper
• Cyclooxygenase 2 and its Metabolites: Implications for Lung Cancer Therapy

  2009cites this paper
• The Aryl Hydrocarbon Receptor Attenuates Tobacco Smoke-induced Cyclooxygenase-2 and Prostaglandin Production in Lung Fibroblasts through Regulation of the NF-κB Family Member RelB*

  2008cites this paper
• Pathway to Elevate Cyclooxygenase 2 Expression and Prostaglandin E 2 Secretion in Human Bronchial Epithelial Cells

  2008cites this paper
• 17-Beta estradiol and hydroxyestradiols interact via the NF-kappa B pathway to elevate cyclooxygenase 2 expression and prostaglandin E2 secretion in human bronchial epithelial cells.

  2008cites this paper
• Interaction between interleukin-17-producing CD4+ T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation?

  2007cites this paper